Clinical Trial Update: Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study [Phase 2]

View source ↗

Summary

This is a Phase 2 pilot trial evaluating aggressive albuminuria reduction in biopsy-proven diabetic kidney disease. The study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Snippet

Sponsor: Iain Bressendorff | Conditions: Diabetic Kidney Disease | Phase 2 | Status: TERMINATED